APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 209 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,510,331 | +10.7% | 92,280 | +165.2% | 0.01% | 0.0% |
| Q2 2023 | $3,169,916 | +50.5% | 34,796 | +9.0% | 0.01% | +80.0% |
| Q1 2023 | $2,105,707 | -34.8% | 31,924 | -48.9% | 0.01% | -50.0% |
| Q4 2022 | $3,231,875 | +15.4% | 62,500 | +52.4% | 0.01% | +11.1% |
| Q3 2022 | $2,801,000 | +4.6% | 41,000 | -30.7% | 0.01% | 0.0% |
| Q2 2022 | $2,677,000 | +71.1% | 59,200 | +92.1% | 0.01% | +80.0% |
| Q1 2022 | $1,565,000 | -31.5% | 30,818 | -55.5% | 0.01% | -37.5% |
| Q3 2021 | $2,284,000 | +55.8% | 69,300 | +198.8% | 0.01% | +33.3% |
| Q2 2021 | $1,466,000 | +53.7% | 23,196 | -20.6% | 0.01% | 0.0% |
| Q2 2020 | $954,000 | +56.7% | 29,225 | +28.7% | 0.01% | +50.0% |
| Q1 2020 | $609,000 | +6.3% | 22,708 | +21.4% | 0.00% | 0.0% |
| Q4 2019 | $573,000 | – | 18,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |